Overview: Filaria IgM TestIntroduction: The Filaria IgM Test detects IgM antibodies to filaria, indicating recent parasitic infection causing swelling or fever. Aligned with 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in serology for patients with suspected active filariasis.
Other Names: Filaria IgM Assay, Recent Filariasis Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Filaria antibody testing began in the 1980s with parasitic research. IgM immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses recent filarial infection, guides antiparasitic therapy, and monitors IgM antibodies in patients with swelling or fever.
Test Parameters: 1. Filaria IgM
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like swelling or fever, and list travel to endemic areas.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document swelling, fever, or travel to filaria-endemic areas. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiparasitic therapy.
Procedural Considerations: Uses an immunoassay to detect filaria IgM antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Cross-reactivity with other parasites may cause false positives. Early infection may cause false negatives.
Clinical Significance: Positive IgM results confirm recent filarial infection, prompting antiparasitic therapy. Negative results may require antigen testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation.
Additional Supporting Tests: Filaria antigen test, filaria IgG, or imaging to confirm filariasis.
Test Limitations: False positives may occur with related parasites. Results require clinical correlation.
References: IDSA Parasitic Guidelines, 2023; Clinical Infectious Diseases, Nutman TB, 2022.
